Motus GI Holdings Profit Margin 2016-2023 | MOTS
Motus GI Holdings Annual Profit Margins |
---|
Motus GI Holdings Quarterly Profit Margins |
---|
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.002B | $0.000B |
Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $40.559B | 22.61 |
Inspire Medical Systems (INSP) | United States | $6.310B | 0.00 |
10x Genomics (TXG) | United States | $4.320B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.563B | 0.00 |
Axonics (AXNX) | United States | $3.517B | 0.00 |
Hims & Hers Health (HIMS) | United States | $3.389B | 0.00 |
Enovis (ENOV) | United States | $3.306B | 25.12 |
Azenta (AZTA) | United States | $3.256B | 265.41 |
Olink Holding AB (publ) (OLK) | Sweden | $2.992B | 0.00 |
Privia Health (PRVA) | United States | $2.249B | 99.84 |
Schrodinger (SDGR) | United States | $1.855B | 0.00 |
Phreesia (PHR) | United States | $1.336B | 0.00 |
Omnicell (OMCL) | United States | $1.281B | 31.34 |
Definitive Healthcare (DH) | United States | $0.916B | 0.00 |
Standard BioTools (LAB) | United States | $0.766B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.644B | 0.00 |
Talkspace (TALK) | United States | $0.608B | 0.00 |
Health Catalyst (HCAT) | United States | $0.439B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.387B | 0.00 |
Pulmonx (LUNG) | United States | $0.346B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.321B | 0.00 |
P3 Health Partners (PIII) | United States | $0.289B | 0.00 |
American Well (AMWL) | United States | $0.242B | 0.00 |
Butterfly Network (BFLY) | United States | $0.208B | 0.00 |
Augmedix (AUGX) | United States | $0.162B | 0.00 |
TruBridge (TBRG) | United States | $0.132B | 5.68 |
Outset Medical (OM) | United States | $0.111B | 0.00 |
MSP Recovery (LIFW) | United States | $0.101B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.096B | 0.00 |
111 (YI) | China | $0.087B | 0.00 |
Future Health ESG (FHLT) | United States | $0.064B | 0.00 |
HeartBeam (BEAT) | United States | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.056B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.040B | 0.00 |
Cue Health (HLTH) | United States | $0.030B | 0.00 |
Akili (AKLI) | United States | $0.030B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.027B | 0.00 |
ETAO (ETAO) | United States | $0.023B | 0.00 |
Movano (MOVE) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.019B | 0.00 |
Centogene (CNTG) | Germany | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.016B | 0.00 |
Syra Health (SYRA) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.011B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Heart Test Laboratories (HSCS) | United States | $0.008B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |